Who Paid My Doc
A Descriptive, Prospective, Multi-Country, Multicentre Study to Assess
Research payments
$1,773,032
Through program year 2024, $1,773,032 in research payments was reported against A Descriptive, Prospective, Multi-Country, Multicentre Study to Assess, across 715 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $14,798 | 10 |
| 2023 | Research | $395,079 | 186 |
| 2022 | Research | $1,042,270 | 505 |
| 2021 | Research | $320,884 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Dawn Black Angleton, TX Named on 81 payments
- John Whitfield Fort Worth, TX Named on 49 payments
- Colleen McNicholas Saint Louis, MO Named on 48 payments
- Melinda Miller-Thrasher Atlanta, GA Named on 40 payments
- Susan Buchbinder San Francisco, CA Named on 39 payments
- Joel Lebed Pottstown, PA Named on 33 payments
- Stephen Pound North Chesterfield, VA Named on 33 payments
- Cedrice Davis Marietta, GA Named on 23 payments
- Carlos Perez Doral, FL Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.